These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2528007)

  • 1. [Clinical application and significance of drug delivery systems in cancer chemotherapy].
    Tsukagoshi S
    Nihon Rinsho; 1989 Jun; 47(6):1295-301. PubMed ID: 2528007
    [No Abstract]   [Full Text] [Related]  

  • 2. SMANCS.
    Duncan R
    Jpn J Cancer Res; 1995 Jun; 86(6):inside front cover. PubMed ID: 7622412
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor-targeted chemotherapy with lipid contrast medium and macro molecular anticancer agents theoretical considerations and clinical outcome].
    Maeda H; Konno T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):773-82. PubMed ID: 2985005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arterial infusion chemotherapy with SMANCS].
    Nekohashi T; Maruno J; Sanjou A; Toda G
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():629-33. PubMed ID: 11762025
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors.
    Nagamitsu A; Greish K; Maeda H
    Jpn J Clin Oncol; 2009 Nov; 39(11):756-66. PubMed ID: 19596662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracavitary administration: pharmacokinetic advantages of macromolecular anticancer agents against peritoneal and pleural carcinomatoses.
    Kimura M; Konno T; Miyamoto Y; Kojima Y; Maeda H
    Anticancer Res; 1998; 18(4A):2547-50. PubMed ID: 9703908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive tumor targeting of soluble macromolecules and drug conjugates.
    Seymour LW
    Crit Rev Ther Drug Carrier Syst; 1992; 9(2):135-87. PubMed ID: 1386002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
    Numasaki Y; Takahashi K; Masuda E; Nohara C; Maeda H
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2289-94. PubMed ID: 1834021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathologic study of hepatocellular carcinoma treated by TAI and TAE with SMANCS].
    Takayasu K; Iwata R; Furukawa T; Nakanishi Y; Sakamoto M
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():70-2. PubMed ID: 9512691
    [No Abstract]   [Full Text] [Related]  

  • 10. [Early phase II study of YM 881 (zinostatin stimalamer) by intravenous injection. Research group for intravenous YM 881].
    Saito T; Nakao I; Wakui A; Niitani H; Kurihara M; Konno T; Tsukagoshi S; Maeda H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1319-23. PubMed ID: 1829883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS.
    Fang J; Sawa T; Maeda H
    Adv Exp Med Biol; 2003; 519():29-49. PubMed ID: 12675206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial administration of SMANCS and other antitumor agents dissolved in lipiodol for various malignant solid tumors].
    Konno T; Iwai K; Maki S; Tashiro S; Miyauchi Y; Maeda H; Yokoyama I
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1151-6. PubMed ID: 6095018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase I clinical study of zinostatin stimalamer (YM 881) by intravenous injection].
    Saito T; Nakao I; Wakui A; Kurihara M; Niitani H; Konno T; Tsukagoshi S; Maeda H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1311-8. PubMed ID: 1829882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPR: Evidence and fallacy.
    Nichols JW; Bae YH
    J Control Release; 2014 Sep; 190():451-64. PubMed ID: 24794900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navelbine: a new step in cancer therapy?
    Armand JP; Marty M
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of giant hepatocellular carcinoma successfully treated by arterial administration of SMANCS].
    Yajima Y; Miyazaki A; Miyasato S; Tomiya Y; Shibuya D; Ohira S; Sakurada H; Ishii K; Kinoshita T
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1325-9. PubMed ID: 8831747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol].
    Konno T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
    Konno T; Maeda H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytostatic drug therapy in the aged].
    Wilmanns W
    Verh Dtsch Ges Inn Med; 1990; 96():286-94. PubMed ID: 2092446
    [No Abstract]   [Full Text] [Related]  

  • 20. [A preliminary report on the treatment of pleural carcinomatosis with SMANCS].
    Kimura M; Kaneda H; Kume S; Matsushita H; Inoue M; Kai M; Takeuchi H; Uemura K
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1023-5. PubMed ID: 11478133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.